Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Experimental group:rhG-CSF, 5ug/kg, combinated with standard treatment
Control group:standard treatment
Sponsors
The First Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
15 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 15-80 years,diagnosed with mild, common, and severe novel coronavirus pneumonia in accordance with the diagnostic criteria for the diagnosis and treatment of novel coronavirus pneumonia issued by the National Health Commission (trial version 5); 2. White blood cell Count < 15.0 x 10^9/L and Lymphocyte Count < 0.8 x10^9/L.
Exclusion criteria
Exclusion criteria: 1. Combining basic diseases such as hypertension, diabetes, and coronary heart disease; 2. Malignant tumor or with a history of malignant tumor; 3. pregnant or lactating women; 4. suffer from severe mental illness; 5. History of unstable angina pectoris or myocardial infarction within 6 months; coronary angiography suggested severe stenosis of the main branches of the coronary arteries; 6. History of cerebral infarction or cerebral hemorrhage within 6 months; 7. People who are intolerant or allergic to rhG-CSF; 8. Patients were judged unsuitable for inclusion in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms;Blood routine;the viral load of 2019-nCOV of throat swab;TBNK cell subsets;TH1/TH2 Cytokine;Chest CT; | — |
Countries
China
Contacts
Public ContactNanshan Zhong
The First Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed